Who Is Really at Risk for Anaphylaxis Due to COVID-19 Vaccine?
The vaccination campaign against the Severe acute respiratory syndrome coronavirus 2 (Sars-Cov-2) started on 8 December 2020 in UK, after the approval of BNT162b2 by the Healthcare products Regulatory Agency (MHRA) [...]
Збережено в:
| Автори: | , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
MDPI AG
2021-01-01
|
| Серія: | Vaccines |
| Предмети: | |
| Онлайн доступ: | https://www.mdpi.com/2076-393X/9/1/38 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|